Simon Douglas
Presidente presso FUSION ANTIBODIES PLC
Patrimonio netto: 61 701 $ in data 30/06/2024
Profilo
Simon Gordon Douglas is currently the Non-Executive Chairman at Fusion Antibodies Plc since 2011, the Non-Executive Chairman at C-Major Ltd.
since 2019, and the Chairman at HexagonFab Ltd.
He previously served as the Chief Executive Officer at Hologic Ltd.
from 1994 to 1998, the Chief Executive Officer at DNA Research Innovations Ltd.
from 2000 to 2004, the Chief Executive Officer & Director at Biofortuna Ltd.
from 2011 to 2019, and the Executive Chairman at Lab901 Ltd.
from 2009 to 2011.
He also held the position of Managing Director at Invitrogen Holdings Ltd.
from 2004 to 2006.
Dr. Douglas has a background in business development as the Manager-Business Development at Zeneca, Inc. He has a graduate and doctorate degree from The University of Southampton.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
|---|---|---|---|---|
| 31/03/2023 | 760 001 ( 0.32% ) | 35 066 $ | 30/06/2024 | |
FUSION ANTIBODIES PLC
0.70% | 14/02/2024 | 668 865 ( 0.70% ) | 26 634 $ | 30/06/2024 |
Posizioni attive di Simon Douglas
| Società | Posizione | Inizio |
|---|---|---|
| FUSION ANTIBODIES PLC | Presidente | 01/09/2011 |
C-Major Ltd.
 C-Major Ltd. Internet Software/ServicesTechnology Services C-Major Ltd. provides safety devices. The company is headquartered in Daresbury, the United Kingdom. | Presidente | 01/09/2019 |
HexagonFab Ltd.
 HexagonFab Ltd. Medical SpecialtiesHealth Technology HexagonFab Ltd. develops biological sensors that enable rapid and cost-effective detection of biological substances such as proteins, DNA, or small molecules. The company is based in Cambridge, UK. The British company's award-winning technology eliminates the need for lengthy and expensive lab processes. The sensors can measure Antibody Antigen kinetics with the HexagonFab Bolt. The company was founded by Ruizhi Wang, Christoph von Bieberstein, Stephan Hofmann. | Presidente | - |
Precedenti posizioni note di Simon Douglas
| Società | Posizione | Fine |
|---|---|---|
| CAMBRIDGE NUTRITIONAL SCIENCES PLC | Presidente | 22/04/2024 |
Biofortuna Ltd.
 Biofortuna Ltd. Medical SpecialtiesHealth Technology Biofortuna Ltd. provides molecular diagnostic solutions. Its products include SSPGo and ReadyPlex. The firm offers design and development, freeze-drying, manufacturing and dispensing and kitting services. The firm offers its technology on a custom service basis to clients from the clinical, veterinary, food, and research sectors. The company was founded by Mike Bunce, Ben Passey and David Charvill in 2008 and is headquartered in Wirral, the United Kingdom. | Amministratore Delegato | 01/01/2019 |
Lab901 Ltd.
 Lab901 Ltd. Medical SpecialtiesHealth Technology At Lab901 the management believe that your time should be dedicated to discovery, not manual and repetitive tasks. Lab901 was founded in 2001 to deliver this vision. Its team combines expertise in automation, electrophoresis, software development and molecular biology biochemistry. The company is proud to introduce ScreenTape, the first fully automated platform for gel electrophoresis. | Presidente | 01/01/2011 |
Invitrogen Holdings Ltd.
 Invitrogen Holdings Ltd. Financial ConglomeratesFinance Part of Thermo Fisher Scientific, Inc., Invitrogen Holdings Ltd. functions as an investment holding British company. The company is based in Paisley, UK. | Amministratore Delegato | 01/01/2006 |
DNA Research Innovations Ltd.
 DNA Research Innovations Ltd. Miscellaneous Commercial ServicesCommercial Services DNA Research Innovations Ltd. conducts DNA based research and develops nucleic acid purification technology. It offers Charge Switch for nucleic acid purification. The company operates as a subsidiary of Invitrogen Corp. DNA Research was founded by Matthew John Baker in 1998 and is headquartered in Sittingbourne, UK. | Amministratore Delegato | 01/01/2004 |
Formazione di Simon Douglas
| The University of Southampton | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 2 |
|---|---|
| CAMBRIDGE NUTRITIONAL SCIENCES PLC | Health Technology |
| FUSION ANTIBODIES PLC | Health Services |
| Aziende private | 10 |
|---|---|
Hologic Ltd.
 Hologic Ltd. Medical SpecialtiesHealth Technology Hologic Ltd. manufactures life sciences products and services with two divisions, Molecular Diagnostics and Research Products & Services. The firm has laboratories, manufacturing and operations in the USA, UK and France. It provides test kits, reagents and services to two synergistic markets. It focuses on these niche opportunities with products, patents, expertise and acquisitions. The company was founded in 1992 and is headquartered in Wythenshawe, the United Kingdom. | Health Technology |
GE Healthcare Ltd. (United Kingdom)
 GE Healthcare Ltd. (United Kingdom) Medical SpecialtiesHealth Technology GE Healthcare Ltd. provides transformational medical technologies and services which include icenter, AssetPlus, preventive maintenance, continuity, digital solutions and Unisys multi brand probe repair services. The firm offers magnetic resonance imaging, hemodynamic recording, EP recording, metabolic health and computed tomography. The company was founded on February 16, 1971 and is headquartered in Little Chalfont, the United Kingdom. | Health Technology |
DNA Research Innovations Ltd.
DNA Research Innovations Ltd. Miscellaneous Commercial ServicesCommercial Services DNA Research Innovations Ltd. conducts DNA based research and develops nucleic acid purification technology. It offers Charge Switch for nucleic acid purification. The company operates as a subsidiary of Invitrogen Corp. DNA Research was founded by Matthew John Baker in 1998 and is headquartered in Sittingbourne, UK. | Commercial Services |
Lab901 Ltd.
Lab901 Ltd. Medical SpecialtiesHealth Technology At Lab901 the management believe that your time should be dedicated to discovery, not manual and repetitive tasks. Lab901 was founded in 2001 to deliver this vision. Its team combines expertise in automation, electrophoresis, software development and molecular biology biochemistry. The company is proud to introduce ScreenTape, the first fully automated platform for gel electrophoresis. | Health Technology |
ICI Group
 ICI Group Industrial SpecialtiesProcess Industries ICI Group is a British company that manufactures paints and coatings. | Process Industries |
| Zeneca, Inc. | |
Invitrogen Holdings Ltd.
Invitrogen Holdings Ltd. Financial ConglomeratesFinance Part of Thermo Fisher Scientific, Inc., Invitrogen Holdings Ltd. functions as an investment holding British company. The company is based in Paisley, UK. | Finance |
Biofortuna Ltd.
Biofortuna Ltd. Medical SpecialtiesHealth Technology Biofortuna Ltd. provides molecular diagnostic solutions. Its products include SSPGo and ReadyPlex. The firm offers design and development, freeze-drying, manufacturing and dispensing and kitting services. The firm offers its technology on a custom service basis to clients from the clinical, veterinary, food, and research sectors. The company was founded by Mike Bunce, Ben Passey and David Charvill in 2008 and is headquartered in Wirral, the United Kingdom. | Health Technology |
C-Major Ltd.
C-Major Ltd. Internet Software/ServicesTechnology Services C-Major Ltd. provides safety devices. The company is headquartered in Daresbury, the United Kingdom. | Technology Services |
HexagonFab Ltd.
HexagonFab Ltd. Medical SpecialtiesHealth Technology HexagonFab Ltd. develops biological sensors that enable rapid and cost-effective detection of biological substances such as proteins, DNA, or small molecules. The company is based in Cambridge, UK. The British company's award-winning technology eliminates the need for lengthy and expensive lab processes. The sensors can measure Antibody Antigen kinetics with the HexagonFab Bolt. The company was founded by Ruizhi Wang, Christoph von Bieberstein, Stephan Hofmann. | Health Technology |
- Borsa valori
- Insiders
- Simon Douglas
